Biospecimen Bank
生物样本库
基本信息
- 批准号:10456958
- 负责人:
- 金额:$ 17.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-02 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:9p24Animal ModelAreaBiodistributionBiological AssayBiological Specimen BanksBiological Specimen databaseBiometryBiostatistics CoreBloodBlood Component RemovalBlood specimenBone MarrowCancer CenterCell SeparationCellsChromosomesCitiesCity of Hope Comprehensive Cancer CenterClassificationClinicalCollaborationsCollectionCommunitiesComplementComplexComprehensive Cancer CenterCore FacilityCytogeneticsCytometryDNA Sequencing FacilityDataData SetDatabasesDerivation procedureDevelopmentDiagnosisDrug KineticsEnrollmentEnsureFundingGene Expression ProfilingGenomicsGoalsHistologicHodgkin DiseaseHumanIL2RA geneImmuneImmunofluorescence ImmunologicImmunophenotypingIndividualInformaticsInfrastructureInstitutionLeukapheresisLinkLymphomaMalignant lymphoid neoplasmModelingMolecularMonitorMulticenter StudiesNon-Hodgkin&aposs LymphomaParaffinPathologicPathologyPatientsPerformancePhenotypePopulationPreparationProcessProgram Research Project GrantsQuality ControlRegistriesResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesSamplingServicesShipsSpecimenStainsTimeTissue MicroarrayTissuesTumor TissueWorkbasiliximabbiomarker evaluationcareerchimeric antigen receptor T cellsdata repositorydesigndisease classificationimprovedinformatics infrastructureleukemia/lymphomamemberpatient derived xenograft modelprogramsprospectivequality assurancespatial relationshiptumortumor microenvironment
项目摘要
Core C is designed to meet the specific needs of the projects and at the same time draw on the strength of the
existing Cancer Center (CC) cores without unnecessary duplication of services. This Core will work closely and
synergistically with a number of CC Cores as well as other SPORE Cores to provide exceptional support for all
the proposed projects and possible inter-SPORE collaborations.
The overarching goals of this core is to provide high quality, well annotated and strictly quality controlled
biospecimens for the projects, to develop and implement assays needed for the analysis of the biospecimens
and to collaborate with Core B to build the informatics infrastructures to facilitate all aspects of research linked
to biospecimens.
Specific Aim 1 is to provides services in the following areas: (1) acquisition and banking of fresh and paraffin-
fixed tissues of lymphoma and blood and bone marrow (BM) samples obtained prospectively and
retrospectively from patients enrolled on the COH lymphoma SPORE; we will ensure rapid collection and
processing, proper storage and monitoring, and proper annotation and record keeping; (2) comprehensive
work-up of lymphoma specimens to ensure correct diagnosis and classification, including
immunohistochemical, flow cytometric, molecular pathologic, and cytogenetic studies; (3) performance and
assistance in routine histologic and immunohistochemical staining of lymphoma tissues and cells, as well as
specialized histologic services such as preparation of multi-tumor blocks or tissue microarrays to the
specifications of researchers. Additional specialized services will be performed according to the needs of the
projects with the collection of leukapheresis specimens to generate CAR-T cells (Project 1); characterization of
complex Hodgkin lymphoma and host cell populations through multispectral multiplexed immunofluorescence
(mIF) phenotyping and gene expression profiling (GEP) (Project 3); cytogenetic and genomic characterization
of lymphomas and the preparation of samples to generate primary patient-derived xenograft (PDX) non-
Hodgkin lymphoma models (Project 4).
Because of the complexity of the datasets associated with the functions of Core C, in Specific Aim 2, we will
collaborate with Core B (Research Informatics) to design, build, and integrate databases relevant to
biospecimens to improve their functionality and connectivity to support SPORE projects and collaborations on
other NCI-sponsored projects.
Core C旨在满足项目的特定需求,同时借鉴了
现有的癌症中心(CC)核心,没有不必要的服务重复。该核心将紧密工作,并且
与许多CC内核以及其他孢子核协同作用,为所有人提供出色的支持
拟议的项目和可能的跨越合作。
该核心的总体目标是提供高质量,注释和严格质量的控制
项目的生物测量,开发和实施分析生物测量所需的测定法
并与核心B合作建立信息学基础架构,以促进链接的研究的各个方面
到生物测量。
具体目标1是在以下领域提供服务:(1)获取和银行新鲜和石蜡 -
淋巴瘤,血液和骨髓(BM)样品的固定组织被前瞻性地获得
回顾性的患者孢子的患者。我们将确保快速收集和
处理,正确的存储和监视以及正确的注释和记录保存; (2)全面
淋巴瘤标本的检查以确保正确的诊断和分类,包括
免疫组织化学,流式细胞仪,分子病理学和细胞遗传学研究; (3)性能和
协助淋巴瘤组织和细胞的常规组织学和免疫组织化学染色以及
专业的组织学服务,例如制备多肿瘤块或组织微阵列
研究人员的规格。其他专业服务将根据
收集白细胞术标本以生成CAR-T细胞的项目(项目1);表征
复杂的霍奇金淋巴瘤和宿主细胞种群通过多光谱的多重免疫荧光
(MIF)表型和基因表达分析(GEP)(项目3);细胞遗传学和基因组表征
淋巴瘤和样品的制备以产生原发性患者衍生的异种移植(PDX)非 -
霍奇金淋巴瘤模型(项目4)。
由于与Core C功能相关的数据集的复杂性,在特定的AIM 2中,我们将
与Core B(研究信息学)合作设计,构建和集成与
生物测量以提高其功能和连接性,以支持孢子项目和合作
其他NCI赞助的项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wing C. Chan其他文献
Large granular lymphocyte proliferation: an analysis of T-cell receptor gene arrangement and expression and the effect of in vitro culture with inducing agents.
大颗粒淋巴细胞增殖:T细胞受体基因排列和表达以及诱导剂体外培养效果的分析。
- DOI:
- 发表时间:
1988 - 期刊:
- 影响因子:20.3
- 作者:
Wing C. Chan;Carol DahI;Thomas A. Waldmann;Susan Link;Alison Mawle;Janet K. A. Nicholson;Fritz H. Bach;K. Bongiovanni;Peter A. McCue;Elliott F. Winton - 通讯作者:
Elliott F. Winton
Lymphomas of follicles. Mantle cell and follicle center cell lymphomas.
滤泡淋巴瘤。
- DOI:
- 发表时间:
1993 - 期刊:
- 影响因子:3.5
- 作者:
D. Weisenburger;Wing C. Chan - 通讯作者:
Wing C. Chan
Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes.
大颗粒淋巴细胞增殖的异质性:两种主要亚型的划分。
- DOI:
- 发表时间:
1986 - 期刊:
- 影响因子:20.3
- 作者:
Wing C. Chan;A. Mawle;Irene J. Check;Russell K. Brynes;Elliott F. Winton - 通讯作者:
Elliott F. Winton
Mechanistic Elucidation of the Tumor-Promoting Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in B-Cell Receptor Signaling in Mantle Cell Lymphoma
- DOI:
10.1182/blood-2023-175064 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Serene Xavier;Vivian Nguyen;Vishal Khairnar;An Phan;Lu Yang;Michael Nelson;Elizabeth Tseng;Aimin Li;Joo Y Song;Dennis D. Weisenburger;Wing C. Chan;Markus Müschen;Vu N. Ngo - 通讯作者:
Vu N. Ngo
<em>PRDM1</em> Deletion and <em>STAT3</em> Mutations Cooperatively Promote CD8<sup>+</sup> T-Cell and NK-Cell Growth <em>in Vitro</em>
- DOI:
10.1182/blood-2022-168184 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Xuxiang Liu;Kunal Shetty;Yuping Li;Jibin Zhang;Alyssa C. Bouska;Javeed Iqbal;Giorgio Inghirami;Wing C. Chan - 通讯作者:
Wing C. Chan
Wing C. Chan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wing C. Chan', 18)}}的其他基金
Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures
生物分析物的分析前变量影响 PTCL 诊断和预后遗传特征的准确性
- 批准号:
10300391 - 财政年份:2021
- 资助金额:
$ 17.65万 - 项目类别:
Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures
生物分析物的分析前变量影响 PTCL 诊断和预后遗传特征的准确性
- 批准号:
10491082 - 财政年份:2021
- 资助金额:
$ 17.65万 - 项目类别:
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
TET2 和 IDH2 突变在血管免疫母细胞 T 细胞淋巴瘤发生中的协同作用
- 批准号:
10672370 - 财政年份:2021
- 资助金额:
$ 17.65万 - 项目类别:
Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures
生物分析物的分析前变量影响 PTCL 诊断和预后遗传特征的准确性
- 批准号:
10684317 - 财政年份:2021
- 资助金额:
$ 17.65万 - 项目类别:
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
TET2 和 IDH2 突变在血管免疫母细胞 T 细胞淋巴瘤发生中的协同作用
- 批准号:
10299140 - 财政年份:2021
- 资助金额:
$ 17.65万 - 项目类别:
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
TET2 和 IDH2 突变在血管免疫母细胞 T 细胞淋巴瘤发生中的协同作用
- 批准号:
10453656 - 财政年份:2021
- 资助金额:
$ 17.65万 - 项目类别:
Development of a Novel Clinical Diagnostic Assay for Peripheral T-cell Lymphoma (PTCL)
开发外周 T 细胞淋巴瘤 (PTCL) 的新型临床诊断方法
- 批准号:
9555564 - 财政年份:2018
- 资助金额:
$ 17.65万 - 项目类别:
Molecular diagnostic and prognostic signatures for PTCL
PTCL 的分子诊断和预后特征
- 批准号:
10017897 - 财政年份:2017
- 资助金额:
$ 17.65万 - 项目类别:
Molecular diagnostic and prognostic signatures for PTCL
PTCL 的分子诊断和预后特征
- 批准号:
10226182 - 财政年份:2017
- 资助金额:
$ 17.65万 - 项目类别:
Molecular Signatures to Improve Diagnosis and Outcome Pr
改善诊断和结果的分子特征
- 批准号:
7913564 - 财政年份:2009
- 资助金额:
$ 17.65万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目